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Abstract 
Background: Peripheral public health facilities remain the most frequented by the majority of the population in 
Kenya; yet remain sub-optimally equipped and not optimized for non-communicable diseases care.
Design and methodology: We undertook a descriptive, cross sectional study among ambulatory type 2 diabetes 
mellitus clients, attending Kenyatta National Referral Hospital (KNH), and Thika District Hospital (TDH) in Central Kenya. 
Systematic random sampling was used. HbA1c was assessed for glycemic control and the following, as markers of 
quality of care: direct client costs, clinic appointment interval and frequency of self monitoring test, affordability and 
satisfaction with care.
Results: We enrolled 200 clients, (Kenyatta National Hospital 120; Thika District Hospital 80); Majority of the patients 
66.5 % were females, the mean age was 57.8 years; and 58 % of the patients had basic primary education. 67.5 % had 
diabetes for less than 10 years and 40 % were on insulin therapy. The proportion (95 % CI) with good glycemic was 
17 % (12.0–22.5 respectively) in the two facilities [Kenyatta National Hospital 18.3 % (11.5–25.6); Thika District Hospital 
15 % (CI 7.4–23.7); P = 0.539]. However, in Thika District Hospital clients were more likely to have a clinic driven routine 
urinalysis and weight, they were also accorded shorter clinic appointment intervals; incurred half to three quarter 
lower direct costs, and reported greater affordability and satisfactions with care.
Conclusion: In conclusion, we demonstrate that in Thika district hospital, glycemic control and diabetic care is sub-
optimal; but comparable to that of Kenyatta National Referral hospital. Opportunities for improvement of care abound 
at peripheral health facilities.
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Background
Diabetes mellitus is a global public health problem of 
epidemic proportions. An estimated 285 million people 
are now living with diabetes worldwide and this figure 
is expected to reach 440 million by year 2030, with the 
largest proportional increase occurring in developing 
countries [1]. Furthermore four out of every five peo-
ple with diabetes live in developing countries, and most 
affected men and women are family bread winners [2].
During the past few decades a rapid increase in the 
prevalence of diabetes has been observed in low-and 
middle income countries, with high prevalence being 
reported even, among low income earner groups. This 
is well illustrated by two studies, that were done in the 
urban slums in Nairobi, The Kibera study [3], which dem-
onstrated that there was a high prevalence of DM yet low 
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screening rates in this previously unstudied slum, and 
the Viwandani and Korogocho study [4], which demon-
strated that Diabetes was on the rise among the poor. In 
the developing countries, not enough is being done to 
provide the least expensive lifesaving diabetes drugs, for 
optimal long term glycemic control, and provide quality 
comprehensive care [5]. Health care systems are predom-
inantly geared towards communicable diseases and not 
enough attention is being accorded to non-communica-
ble diseases [6].
Studies indicate that treatment and control of Diabetes 
can be highly cost effective because medical care expen-
ditures are avoided when therapy defers or delays the 
development of complications [7]. In Sub Saharan Africa, 
evidence indicates that much of the death and disability 
related to diabetes can be prevented with cost effective 
interventions [8].
Glycosylated hemoglobin recommended by the Ameri-
can Diabetes Association as the preferred and effective 
measure of glucose control and a target of less than 7.0 % 
is advised for most patients. It is useful in assessing the 
effectiveness of therapy and guiding the therapeutic deci-
sions and as such is a useful measure of quality of care.
Barriers to quality diabetic care include lack of a defi-
nite policy addressing chronic illness, limited resources, 
restricted spectrum of care, and lack of information to 
the public and psychological factors. Emphasis in care 
has been on drug therapy, but omitting components such 
as education, nutrition counseling and psychosocial sup-
port [9]. These challenges are compounded by regionally 
unique social, cultural and economic issues [10]. Stud-
ies have also shown that clients perceive psychological 
issues as the most important barrier to diabetes care; [11] 
besides the strictness of the diabetes regimen, includ-
ing dietary, exercise, self-glucose monitoring, clinician 
review, and medication activities [12].
In Kenya the National Diabetes strategy 2010–2015 
estimates Diabetes prevalence at 3.3  % with a projected 
rise to 4.5 %, in 2025, translating to 1.8 million Kenyans 
living with Diabetes [13]. With her per capita GPD esti-
mated at $1200 a year most diabetics even with subsidies 
are unable to afford diabetes health care,that is the cost 
of drugs, transportation and laboratory test [14]. Hence 
making diabetes care unaffordable to those who really 
need it.
Peripheral public health facilities where the majority of 
the affected Kenyan population seek health care services 
continues to be sub optimally equipped and not geared to 
non-communicable diseases care. This has led to widely 
held perception that person with diabetes can only get 
quality medical care from the tertiary health facilities, 
which has contributed to an over bearing, self-referral, 
patient load at the limited number of tertiary facilities. 
Services at tertiary facilities are costly and is further 
compounded by the other indirect client costs including 
transport [15].
Provision of quality diabetic care at peripheral facili-
ties is best suited towards making care and management 
reachable to majority of Kenyans who need it.
The objective of this study was therefore to compare 
quality of diabetes care provision, level of glycemic con-
trol and direct patients cost, at a tertiary referral hospital 
to that at a regional hospital in Central Kenya.
Methods
This was a comparative cross-sectional study conducted 
at Kenyatta National Referral Hospital (KNH) and Thika 
District Hospital (TDH) in Kenya. KNH is situated in 
the Kenya’s capital city, Nairobi, approximately 2  km to 
the west of the city Centre, KNH is one of two national 
referral hospital and is also a teaching hospital for the 
University of Nairobi’s College of Health Sciences. The 
Hospital has a bed capacity is 1800 and 4800 members of 
staff. KNH runs specialized diabetics clinic managed by a 
team of specialist, endocrinologists, physicians, graduate 
resident doctors, nutritionists, diabetic educators, medi-
cal assistants, and nurses. Approximately 400 diabetic cli-
ents are seen in a week at clinics that run daily excluding 
weekends. TDH is a primary health care facility located 
80 km to the east of Nairobi City. The health facility has 
a bed capacity is 250 and 500 members of staff. TDH 
runs a single weekly diabetic outpatient clinic once that 
attends to approximately 80 clients. The team of clini-
cians includes medical officers, medical assistants, nurs-
ing practitioners and a nutritionist. The study was carried 
out among ambulatory Type II DM clients, receiving 
care and follow-up at the selected facilities. Inclusion 
criteria was clients above 18  years of age, diagnosed at 
least 6  months earlier and on glucose lowering therapy 
for at least 3 months. Patients diagnosed to have type 1 
diabetes mellitus (WHO criteria), pregnant females and 
patients diagnosed or documented to have psychological 
or mental disorders were excluded.
Sampling, recruitment and data collection
The clients who met the inclusion criteria and provided 
written consent were systematically sampled, by recruit-
ing every third client. Structured questionnaires were 
administered by two study investigators (SMM and ENK) 
assisted by two trained research assistants, to capture 
data on socio-demographic characteristics, co-mor-
bidities and diabetes diagnosis and management vari-
ables. Patients were questioned on direct out of pocket 
expenses incurred per clinic visit, clinic appointment 
intervals and patients perceived accessibility to and 
affordability of care and treatment. Furthermore they 
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were asked to indicate whether they were satisfied or not 
with the level of current care provided. Level of adher-
ence to oral treatment was established using the Morisky 
scale giving three categories of high, intermediate and 
low adherence. A finger-prick blood sample was obtained 
from each patient for HbA1c measurement after each 
interview. HbA1c was measured onsite using Bayer 
A1CNow®, a portable, easy-to-use device capable of pro-
viding HbA1c results in 5 mins. This had the advantage 
of communicating the results to the patient immediately. 
Quality control for the HbA1c tests was done by drawing 
1.0 ml venous blood samples from every 20th patient and 
transported on the same day to an external accredited 
laboratory for the test [16, 17].
Ethical considerations
The study received approval from the Kenyatta National 
Hospital (KNH)/University of Nairobi (UON) Ethics 
and Research Committee. Permission to collect data was 
obtained from the Administration of KNH and the TDH.
Statistical analysis
Statistical analysis was performed using SPSS version 18.0. 
Chi square test was used to test associations between cat-
egorical variables with an alternative of Fisher’s exact test 
used where the numbers were small. Comparison of means 
was done using Student’s t test and Mann–Whitney U test 
to compare medians. Odds ratio was used to estimate the 
relative risk of good glycemic control in association with 
categorical independent variables. Pearson correlation was 
done to compare point of care HbAIC results with the lab-
oratory Hba1c result. All statistical tests were performed 
at 95 % confidence level and statistical significance consid-
ered at p value of less or equal to 0.05.
Results
Between August and October 2012 we screened 210 
diabetic clinic clients, excluded ten and enrolled 200, 
who were included in the final analysis; 120 (60 %) were 
from Kenyatta National Hospital (KNH) and 80 (40  %) 
from Thika District Hospital (TDH). Reasons for exclu-
sion included: two clients who were pregnant and below 
18  years of age, three had a diagnosis of type 1 diabe-
tes, and three had been enrolled into care for less than 
3 months.
Demographic characteristics
The mean age of the clients was 57.8 years (SD 12.3 years) 
of which 66.5 % were females. Majority (58 %) of the cli-
ents had achieved primary level of education, 99 % were 
of Christian faith and 80  % married (Table  1). Age, sex 
and education distribution between the two facilities 
were not significantly different.
Diabetes mellitus characteristics
Among the entire sample 67.5 % of clients had a duration 
of diabetes diagnosis of less than 10 years, however this 
proportion was significantly higher among TDH clients 
(TDH 80  %; KNH 59.2  %; P =  0.002) (Table  2). Diabe-
tes had been diagnosed at screening exercise in 47.5  % 
and on illness evaluation in 51.5  %. Hypertension was 
the most common co-morbidity recorded in 57 %. Insu-
lin therapy was used by 40  % of the clients with a sig-
nificantly larger proportion among KNH patients (KNH 
63.3 %; TDH 5 %; P = <0.001).
Glycemic control
Good glycemic control defined on basis of HBAIC was 
detected in 17 % of the study patients (95 % CI 12.0–22.5) 
and did not differ between the two facilities (Table  3). 
[KNH 8.3  % (95  % CI 11.5–25.6); TDH 15  % (95  % CI 
7.4–23.7); P = 0.539].
Comparison between the HbA1c values between point 
of care A1C and laboratory HbA1c using the paired t 
test showed no significance. [POC 8.3 (1.2) QC 7.8 (1.2) 
P = <0.211] (Table 4).
On bivariate and multivariate analysis (Table 5) com-
pliance to medication was the only variable associated 
with good control (adjusted OR 3.2, 95  % CI 1.4–7.6 
(Table  6)with no facility differential effect. Half of the 
clients (50.5  %) had a high level adherence to diabe-
tes medication, with a higher proportion among KNH 
clients (KNH 45  %; TDH 58.8  %; P  =  0.057). Overall, 
51.5 % of the clients did not do out of clinic blood sugar 
monitoring (self-monitoring or otherwise) and this 
was not significantly different between KNH and TDH. 
However, 29.5 and 19  % of the clients reported having 
their blood monitored on a monthly and weekly basis 
respectively.
Table 1 Socio-demographic characteristics
Variable Overall n (%) KNH n (%) TDH n (%) P value
Mean age (SD) 57.8 (12.3) 56.9 (12.8) 59.0 (11.3) 0.351
Gender
 Female 133 (66.5) 77 (64.2) 56 (70.0) 0.247
Highest level of education
 Primary 116 (58.0) 63 (52.5) 53 (66.3) 0.054
 Secondary 84 (42.0) 57 (47.5) 27 (33.7)
Religion/faith
 Christian 198 (99.0) 118 (98.3) 80 (100.0) 0.518
Marital status
 Married 160 (80.0) 98 (81.7) 62 (77.5) 0.734
 Single 8 (4.0) 4 (3.3) 4 (5.0)
 Separated/divorced/
wido wed
32 (16.0) 18 (15.0) 14 (17.5)
Page 4 of 8Mwavua et al. BMC Res Notes  (2016) 9:12 
Measures of quality of care
Clinic appointment and evaluations, majority (85  %) of 
clients at both hospitals reported regular attendance 
at their scheduled clinic appointments. The intervals of 
scheduled clinic appointments ranged from fortnightly 
to six monthly; 67.5  % were scheduled three monthly 
and 29.5 % six monthly (Table 7). The proportion of cli-
ents receiving one to three monthly appointments was 
92.6 and 50.8 % at TDH and KNH respectively. However 
46.7 % of clients in KNH were scheduled at six monthly 
intervals.
The clinical evaluations routinely made at clinic visits 
included, random blood sugar in 99.5 %, blood pressure 
(BP) measurement in 97.5 %, weight in 37 % and urinaly-
sis in 16.5 % (Table 7). HBAIC was done in 2.5 % of cli-
ents; 4.2 % at KNH and none at TDH. Urinalysis, weight 
measurement were significantly more frequently done 
at TDH compared to KNH (TDH 30.5  %; KNH 7.5  %; 
P  =  <0.001 respectively). Proportion of clients given 
lifestyle change advice counseling was: 93.5  %; special 
prescribed diet (KNH 90.8  %; TDH 97.5  %; P  =  0.061) 
and 64.5  %, on weight loss (KNH 75.8  %; TDH 47.5  %; 
P < 0.001).
Drug availability
Overall, 92 % of the clients reported that drugs for dia-
betes were available in both facilities. Availability of all 
diabetic drugs was reported more frequently in KNH 
(27.5 %) than in TDH (27.5 %; 7.5 %; P = <0.001) while 
none availability was more common at TDH than at 
KNH (16.3 %; 2.5 %; P < 0.001).
Cost of care 
Clients’ means of transport to clinic was predominantly 
public transport. However, use of private means was 
significantly higher at KNH (12.5  %) and a (Table  8) 
higher proportion of TDH (11.3  %) clients walked 
to clinic. Clients at KNH spent significantly higher 
amount of money in Kenya shillings (Kshs) on trans-
port (median value in Kshs 400.0 KNH; 160 TDH), 
consultation (median Kshs KNH 550.0; TDH 100.0) 
and on oral glycemic agents (median Kshs KNH 1000.0; 
TDH 300). The cost of insulin was the same at the two 
facilities.
Accessibility, affordability and satisfaction
The proportion of clients reporting that they were sat-
isfied with current care, found it easily accessible, 
and affordable was 92.5  % (KNH 90.8  %; TDH 95  %; 
P = 0.273), 61.5 % (KNH 53.3 %; TDH 73.8 %; P = 0.004) 
and 90  % respectfully (Table  3). Majority (84  %) of the 
clients reported that they would not transfer to another 
health facility for management of their diabetes illness 
(TDH 91.3 %; KNH 78.8 %: P = 0.020).
Discussion
We set out in this study to compare the quality of out-
patient follow-up care offered to persons with type 2 dia-
betes mellitus at a referral and regional level hospital in 
Kenya; on the premise widely held by patients that higher 
quality of care is offered at tertiary facilities. However, we 
report that the level of glycemic control, as documented 
by HbA1c levels, is poor and comparable at both facilities. 
Less than 20 % of clients were well controlled. Drug com-
pliance levels were also low and compliance was the only 
multivariate predictor of poor control. Low compliance lev-
els are reported despite more than three quarter of clients 
reporting honoring their clinic appointments. Insulin avail-
ability and cost were the same but oral hypoglycemic drugs 
were more frequently unavailable at the peripheral center.
As markers of quality of care offered, clients at the 
regional facility were more likely to have a clinic driven 
routine urinalysis and weight done, and were accorded 
shorter clinic appointment intervals. Direct costs 
incurred by patient were half to three quarter lower at 
the regional facility. Compared to tertiary facility clients, 
regional facility clients reported greater affordability and 
Table 2 Disease and treatment characteristics
Variable Overall n (%) KNH n (%) TDH n (%) P value
Duration of diabetes
 ≤10 years 135 (67.5) 71 (59.2) 64 (80.0) 0.002
 ≥10 years 65 (32.5) 49 (40.8) 16 (20.0)
Diabetes and co-morbidities
 Hypertension 114 (57.0) 66 (55.0) 48 (60.0) 0.484
 Asthma 7 (3.5) 4 (3.3) 3 (3.8) 1.000
 Stroke 4 (2.0) 2 (1.7) 2 (2.5) 1.000
 Arthritis 14 (7.0) 5 (4.2) 9 (11.3) 0.054
Diabetes diagnosis
 Routine hospital 
check up
13 (6.5) 7 (5.9) 6 (7.5) 0.640
 Screened during 
medical camp
95 (47.5) 57 (48.3) 38 (47.5) 1.000
 Sick with symptoms 
of diabetes
90 (45.0) 54 (45.8) 36 (45.0) 1.000
 Not stated 2 (1.0)
Current treatment/advice
 Insulin 80 (40.0) 76 (63.3) 4 (5.0) <0.001
 Special prescribed 
diet
187 (93.5) 109 (90.8) 78 (97.5) 0.061
 Advice/treatment to 
lose weight
129 (64.5) 91 (75.8) 38 (47.5) <0.001
Frequency of blood sugar monitoring
 Daily/ weekly 38 (19.0) 23 (19.2) 15 (18.9) 0.780
 Monthly 59 (29.5) 33 (27.5) 26 (32.5)
 Don’t test 103 (51.5) 64 (53.3) 39 (48.8)
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satisfactions with care offered, and were less inclined to 
transfer care to other centers.
We are not aware of studies in Kenya comparing dia-
betic care between centers. However, studies on level of 
glycemic control at Kenyatta National Hospital have been 
documented; a cross-sectional descriptive study done in 
2012 at the outpatient diabetes clinic of KNH reported 
that only 20  % of patients had ever done at least one 
HbA1c check [18].
In another study done in 1998 in KNH they found that 
Most patients (71 or 68 %) had very poor long-term gly-
cemic control with an HbA1c level >10.0 %, concluding 
that the majority of ambulatory diabetic patients attend-
ing the out-patient diabetic clinic had poor glycemic con-
trol [19].
In a 2002 retrospective study on review of clinical 
records that was performed in Kwa Zulu natal district 
in South Africa and Random blood glucose, hemoglobin 
Table 3 Factors associated with glycemic control
Variable Glycemic control OR (95% CI) P value
Good (HbA1c<7) Poor (HbA1c≥7)
Age 59.6 (12.4) 57.4 (12.3) – 0.351
Gender
 Female 22 (64.7) 111 (66.9) 0.9 (0.4–2.0) 0.808
 Male 12 (35.3) 55 (33.1) 1.0
Highest level of education
 None 5 (14.7) 29 (17.5) 1.0
 Primary 14 (41.2) 68 (41.0) 1.2 (0.4–3.6) 0.754
 Secondary 10 (29.4) 51 (30.7) 1.1 (0.4–3.7) 0.829
 Tertiary 5 (14.7) 18 (10.8) 1.6 (0.4–6.4) 0.493
Duration of diabetes
 ≤10 years 26 (76.5) 109 (65.7) 1.7 (0.7–4.0) 0.220
 More than 10 years 8 (23.5) 57 (34.3) 1.0
Frequency of self monitoring
 Daily/weekly 3 (8.8) 35 (21.1) 1.0
 Monthly 11 (32.4) 48 (28.9) 2.7 (0.7–10.3) 0.141
 Don’t test 20 (58.8) 83 (50.0) 2.8 (0.8–10.1) 0.100
Frequency of clinic visits
 Weekly/fortnightly 1 (2.9) 5 (3.0) 1.0
 Monthly 22 (64.7) 113 (68.1) 1.0 (0.1–8.7) 1.000
 6 months 11 (32.4) 48 (28.9) 1.1 (0.1–10.8) 1.000
Accessibility
 Easy 31 (91.2) 154 (92.8) 0.8 (0.2–3.0) 0.724
 Difficult 3 (8.8) 12 (7.2) 1.0
Affordability
 Affordable 19 (55.9) 104 (62.7) 0.8 (0.4–1.6) 0.460
 Not affordable 15 (44.1) 62 (37.3) 1.0
Satisfaction
 Satisfied 33 (97.1) 165 (99.4) 0.2 (0.0–3.3) 0.312
 Not satisfied 1 (2.9) 1 (0.6) 1.0
Compliance
 High adherence 24 (70.6) 77 (46.4) 2.8 (1.2–6.2) 0.010
 Intermediate/low adherence 10 (29.4) 89 (53.6) 1.0
Diabetic drugs availability
 Yes all the drugs 31 (79.5 %) 8 (20.5 %) 1.0 0.637
 Yes some drugs are available 120 (82.8 %) 25 (17.2 %) 1.2 (0.5–3.0) 0.221
 No 15 (93.8 %) 1 (6.3 %) 3.9 (0.4–33.8)
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A1c (HbA1c) and urine albumin/creatinine ratio assayed 
it Acceptable glycemic control (HbA1c  <  2  % above 
normal population range) was found in only 15.7  % of 
subjects (95  % confidence interval (CI): 11.4–20.8  %). 
Mean HbA1c was 11.3 %, therefore concluding that care 
and control of diabetes in this rural community was sub 
optimal [20].
A prospective cohort study done in 2008 at Mekelle 
Hospital in northern Ethiopia concluded that in this 
severely resource- limited areas, glycemic control 
amongst diabetic clients was very poor, and attributed 
this to scattered populations, shortage of drugs and insu-
lin and lack of diabetes team care as major contributing 
major factors [21].
In another cross sectional, descriptive study done at 
the University of Benin Teaching Hospital, Benin City, 
a tertiary health facility in Nigeria, between June and 
December 2004, it showed that many of the persons with 
diabetes mellitus in Benin city still had poor glycemic 
control similar to previous reports [22].
A study in Finland concluded that the follow-up of 
most diabetic patients—including type 1 diabetes—can 
be organized in primary health care with the same quality 
as in secondary care units. The centralized primary care 
of type 1 diabetes is less, costly and requires fewer spe-
cialist consultations [23].
Table 4 HbA1c paired t test comparison
POC EQA P value
HbA1c 8.3 (1.2) 7.8 (1.2) 0.211
Table 5 Bivariate and  multivariate analysis: predictors 
of good control
Variable OR (95 % CI) P value
Age 1.02 (0.98–1.05) 0.386
Gender
 Female 1.0 (0.4–2.4) 0.972
 Male 1.0
Highest level of education
 Below primary 0.8 (0.3–1.8) 0.519
 Above secondary 1.0
Duration of diabetes
 ≤10 years 1.0
 More than 10 years 0.5 (0.2–1.3) 0.138
Frequency of self-monitoring
 Daily/weekly 1.0
 Monthly 2.6 (0.6–10.7) 0.176
 Don’t test 3.3 (0.8–12.6) 0.086
Appointment intervals clinic visits
 Weekly/fortnightly 1.0
 Monthly 1.0 (0.1–10.0) 0.998
 6 months 1.2 (0.1–12.7) 0.877
Compliance
 High Adherence 3.2 (1.3–7.6) 0.009
 Intermediate/low adherence 1.0
Diabetic drugs availability
 Yes all the drugs 1.0
 Yes some drugs are available 0.8 (0.3–2.1) 0.588
 No 0.3 (0.0–2.5) 0.247
Table 6 Compliance of the patients to medication
Variable Overall KNH TDH P value
n (%) n (%)
Morisky scale
 High adherence 101 (50.5) 54 (45.0) 47 (58.8) 0.057
 Intermediate /low adher-
ence
99 (49.5) 66 (55.0) 33 (41.2)
Would you visit any other health facility for the management of your 
diabetes?
 Yes 32 (16.0) 25 (21.2) 7 (8.8) 0.020
 No 168 (84.0) 93 (78.8) 73 (91.3)






How frequent are clinic visits
 Week/fortnightly 6 (3.0) 3 (2.5) 3 (3.8) <0.001
 Between 1–3 month 135 (67.5) 61 (50.8) 74 (92.6)
 6 months 59 (29.5) 56 (46.7) 3 (3.8)
Attend clinical appointments as scheduled
 Yes 170 (85.0) 102(85.0) 68 (85.0) 1.000
 No 30 (15.0) 18 (15.0) 12 (15.0)
Tests during routine check up
 RBS 199 (99.5) 119 (99.2) 80 (100.0) 1.000
 BP 195 (97.5) 115 (95.8) 80 (100.0) 0.159
 HbA1c 5 (2.5) 5 (4.2) 0 (0.0) 0.159
 Urinalysis 33 (16.5) 9 (7.5) 24 (30.0) <0.001
 WT 74 (37.0) 28 (23.3) 46 (57.5) <0.001
Ever missed medications in past 6 months?
 Yes 46 (23.0) 29 (24.2) 17 (21.3) 0.631
 No 154 (77.0) 91 (75.8) 63 (78.8)
Are Diabetic drugs always available
 Yes all the drugs 39 (19.5) 33 (27.5) 6 (7.5) <0.001
 Yes some drugs are  
available
145 (72.5) 84 (70.0) 61 (76.3)
 No 16 (8.0) 3 (2.5) 13 (16.3)
IF DM drugs unavailable, source?
 Chemist 159 (98.8) 85 (97.7) 74 (100.0) 0.500
 Don’t buy 2 (1.2) 2 (2.3) 0 (0.0)
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Another study in China concluded that the overall 
status of glycemic control was unsatisfactory. Although, 
patients at tertiary hospitals appeared to have better 
control than those at primary or secondary hospitals [24, 
25].
Implications of findings
Our findings point to the need for policy makers to 
focus their attention on strategies that address qual-
ity of care at both regional and tertiary facilities. Tar-
geted interventions at improving care and facilities 
at peripheral centers will help patient’s access better 
health care and thus achieve good glycemic control with 
the attended benefits of complication and cost savings. 
Decentralization of diabetes care to county, sub-county 
and health centers is therefore important to enable suc-
cess in care and management of diabetes at lower care 
levels and only have complicated cases referred to ter-
tiary facilities.
Strengths and limitations
To the best of our knowledge, our study is the first to 
compare quality of regional and tertiary center diabetic 
care in Kenya. A further strength is use of the guide-
line validated and recommended measure of HbA1c for 
glycemic control. Though we relied on qualitative non-
standardized patient dependent information for some of 
the measure of quality of care, for purpose of compari-
son, we have no reason to believe that any bias would be 
differential.
Conclusions
In conclusion we demonstrate that regional glycemic 
control and diabetic care is suboptimal but comparable 
to that of a national tertiary center. However, several 
measures of diabetic care at the regional facility were bet-
ter and more affordable and satisfying to clients. Further-
more measures to improve diabetes care at regional care 
facilities are readily evident.
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Are you usually accompanied when coming to the clinic?
   Yes 70 (35.0) 48 (40.0) 22 (27.5) 0.069
   No 130 (65.0) 72 (60.0) 58 (72.5)
Which means of transport do you use when attending the clinic?
 Public means 167 (83.5) 99 (82.5) 68 (85.0) 0.641
 Private means/walking 33(16.5) 21 (17.5) 12 (15.0)
Variable Overall KNH TDH
How much do you spend on transport per clinic day?
 Median (IQR) 250 (165–600) 400 (200–1000) 160 (100–200)
How many clinics do you visit per month?
 Mean (SD) 1.0 (0.2) 1.0 (0.1) 1.1 (0.2)
How much do spend on transport to the clinic every month?
 Median (IQR) 280 (185–600) 400 (200–1000) 160 (100–220)
Consultation fees
 Mean (SD) 550 (100–550) 554.0 (35.3) 105.6 (50.3)
Insulin
 Mean (SD) 370 (350–400) 439.4 (201.9) 456.7 (75.1)
Medicine fees
 Median (IQR) 700 (300–1500) 1000 (600–2000) 300 (200–400)
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